BioAmber Raises Funds to Accelerate Commercialization of Biosuccinic Acid and Modified PBS
BioAmber announced that it has closed $45 million worth Series B financing round to fund adipic and succinic platforms. The round was by an European-based capital fund company, NAXOS Capital Partners.
The funds will hasten the commercialization of modified PBS (polybutylene succinate polymers) and biobased succinic acid. Mitsui is a new investor in BioAmber. The financing round has been co-led by Sofinnova Partners, largest shareholder in BioAmber. Other inventors participating in the round are Cliffton Group and Mitsui & Co. Venture Partners.
The Series B financing will help the company to reinforce its status as the market leader in biosuccinic acid and will also support the construction of a commercial-scale manufacturing facility in North America. In addition, the investor round will fund BioAmber’s development activities that are progressing in the succinic acid field. The work includes development of innovative purification process along with MATRIC, conversion of succinic acid into to 1,4-butanediol (BDO) using the DuPont-licensed technology, production of biosuccinic acid using non-food feedstock and development of second generation organism with Cargill.
The company will strengthen its management and in-house research and development capabilities to speed up its adipic acid platform development.
Please use one of the following formats to cite this article in your essay, paper or report:
APA
Chai, Cameron. (2019, February 09). BioAmber Raises Funds to Accelerate Commercialization of Biosuccinic Acid and Modified PBS. AZoM. Retrieved on February 15, 2026 from https://www.azom.com/news.aspx?newsID=29054.
MLA
Chai, Cameron. "BioAmber Raises Funds to Accelerate Commercialization of Biosuccinic Acid and Modified PBS". AZoM. 15 February 2026. <https://www.azom.com/news.aspx?newsID=29054>.
Chicago
Chai, Cameron. "BioAmber Raises Funds to Accelerate Commercialization of Biosuccinic Acid and Modified PBS". AZoM. https://www.azom.com/news.aspx?newsID=29054. (accessed February 15, 2026).
Harvard
Chai, Cameron. 2019. BioAmber Raises Funds to Accelerate Commercialization of Biosuccinic Acid and Modified PBS. AZoM, viewed 15 February 2026, https://www.azom.com/news.aspx?newsID=29054.
We're committed to providing free access to quality science. By registering and providing insight into
your preferences you're joining a community of over 1m science interested individuals and help us to
provide you with insightful content whilst keeping our service free.
or
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.